| FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data D Nicorici, M Şatalan, H Edgren, S Kangaspeska, A Murumägi, ... biorxiv, 011650, 2014 | 414 | 2014 |
| Identification of fusion genes in breast cancer by paired-end RNA-sequencing H Edgren, A Murumagi, S Kangaspeska, D Nicorici, V Hongisto, K Kleivi, ... Genome biology 12, 1-13, 2011 | 398 | 2011 |
| Characterization of regulatory elements and methylation pattern of the autoimmune regulator (AIRE) promoter A Murumägi, P Vähämurto, P Peterson Journal of Biological Chemistry 278 (22), 19784-19790, 2003 | 67 | 2003 |
| Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo G Högnäs, S Tuomi, S Veltel, E Mattila, A Murumägi, H Edgren, ... Oncogene 31 (31), 3597-3606, 2012 | 61 | 2012 |
| Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML D Malani, A Murumägi, B Yadav, M Kontro, S Eldfors, A Kumar, ... Leukemia 31 (5), 1187-1195, 2017 | 56 | 2017 |
| Kallioniemi Oet al D Nicorici, M Satalan, H Edgren, S Kangaspeska, A Murumagi FusionCatcher-a tool for finding somatic fusion genes in paired-end RNA …, 2014 | 9 | 2014 |
| BioRxiv D Nicorici, H Satalan, H Edgren, S Kangaspeska, A Murumagi, ... | 8 | 2014 |
| Inga rye, sandra nyberg, maija wolf, anne lise borresen dale et olli kallioniemi: Identification of fusion genes in breast cancer by paired-end rna-sequencing H Edgren, A Murumagi, S Kangaspeska, D Nicorici, V Hongisto, K Kleivi Genome Biology 12 (1), R6, 2011 | 6 | 2011 |
| High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options … CA Heckman, M Kontro, T Pemovska, S Eldfors, H Edgren, E Kulesskiy, ... Blood, The Journal of the American Society of Hematology 120 (21), 288-288, 2012 | 3 | 2012 |
| FusionCatcher-a tool for finding somatic fusion genes in paired-end RNA-sequencing data. bioRxiv. 2014: 1–11 D Nicorici, M Satalan, H Edgren, S Kangaspeska, A Murumagi, ... | 3 | |
| Identification and clinical exploration of individualized targeted therapeutic approaches in acute myeloid leukemia patients by integrating drug response and deep molecular … D Malani, A Kumar, B Yadav, M Kontro, S Potdar, S Eldfors, J Saarela, ... Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 854-854, 2017 | 2 | 2017 |
| Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells A Murumagi, A Hirasawa, S Khan, M Arjama, T Pellinen, ... International Journal of Gynecological Cancer 26, 653-653, 2016 | 1 | 2016 |
| Personalized treatment selection for therapy-resistant AML by integrating ex-vivo drug sensitivity and resistance testing (DSRT) as well as serial genomic, transcriptomic and … NPK Venkata, M Kontro, H Edgren, S Eldfors, T Pemovska, E Kulesskiy, ... Cancer Research 72 (8_Supplement), 4580-4580, 2012 | 1 | 2012 |
| Exome sequencing reveals both DNA sequence and copy number changes in AML: Potential driver changes and mechanisms of drug resistance revealed from serial samples from the same … R Karjalainen, S Eldfors, H Edgren, NPK Venkata, M Kontro, ... Cancer Research 72 (8_Supplement), 5067-5067, 2012 | 1 | 2012 |
| Anagrelide, a novel anticancer compound for gastrointestinal stromal tumor OP Pulkka, Y Gebreyohannes, A Wozniak, JP Mpindi, O Tynninen, K Icay, ... European Journal Of Cancer 103, E127-E128, 2018 | | 2018 |
| High-throughput drug sensitivity and resistance testing of ovarian cancer cell lines provides useful strategy for assessing drug repositioning and therapeutic possibilities of … A Hirasawa, A Murumagi, M Arjama, B Yadav, JP Mpindi, K Wennerberg, ... Clinical Cancer Research 21, 2015 | | 2015 |
| OUTCOME OF PERSONALIZED THERAPY BASED ON HIGH-THROUGHPUT EX VIVO DRUG SCREENING IN PATIENTS WITH RELAPSED, CHEMOREFRACTORY ACUTE MYELOID LEUKEMIA (AML) M Kontro, T Pemovska, E Kulesskiy, H Edgren, S Eldfors, E Elonen, ... HAEMATOLOGICA 98, 19-20, 2013 | | 2013 |
| HIGH-THROUGHPUT DRUG SENSITIVITY AND RESISTANCE TESTING (DSRT) COMBINED WITH MOLECULAR PROFILING FOR THERAPEUTIC TARGETING OF NUP98-NSD1-POSITIVE AML M Kontro, T Pemovska, M Majumder, H Edgren, S Eldfors, E Kulesskiy, ... HAEMATOLOGICA 98, 488-488, 2013 | | 2013 |
| Comprehensive ex vivo drug sensitivity testing combined with in depth molecular profiling of AML patients cells provides individualized treatment strategies and reveals … K Wennerberg, T Pemovska, M Kontro, B Yadav, E Kulesskiy, H Edgren, ... Cancer Research 73 (8_Supplement), 65-65, 2013 | | 2013 |
| Identifying AML-specific key targeted drugs using high-throughput drug sensitivity and resistance testing profiles of AML cells. D Malani, A Murumägi, T Pemovska, B Yadav, E Kulesskiy, J Tang, ... Cancer Research 73 (8_Supplement), 5220-5220, 2013 | | 2013 |
